Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • x Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • x Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (1)
Poster categories
  • e-Thematic Poster Session (20)
  • Thematic Poster Session (137)
keywords
Session Reference
  • L-TPS02 (14)
  • L-TPS09 (7)
  • L-TPS10 (12)
  • L-TPS11 (2)
  • L-TPS16 (14)
  • L-TPS18 (5)
  • L-TPS19 (1)
  • TPS06 (9)
  • TPS07 (11)
  • TPS08 (1)
  • TPS09 (4)
  • TPS19 (1)
  • TPS25 (1)
  • TPS28 (1)
  • TPS29 (15)
  • TPS30 (11)
  • TPS31 (15)
  • TPS32 (2)
  • TPS37 (1)
  • TPS51 (9)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS69 (1)
  • TPS72 (6)
204 results
Thumbnail

D2.144 - Occupational Asthma due to garlic powder: a case report

Thumbnail

D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis

Thumbnail

D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge

Thumbnail

D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients

Thumbnail

D1.405 - Immunological imprinting of IgG response to RV VP1 in children of the MAS and PAPS birth cohorts

Thumbnail

000766 - Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience

Thumbnail

001066 - The Impact of Bee Sting Experiences on Quality of Life and Perceived Health Threat in Korean Beekeepers with Bee Venom Allergy

Thumbnail

100085 - Code Anaphylaxis: enhancing the management of Hymenoptera venom anaphylaxis

Thumbnail

D1.162 - Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Thumbnail

D2.75 - Allergy to insects in children

Thumbnail

D3.423 - Cross-Reactivity Among Hymenoptera Venoms: A Case Study on Apis, Vespula, and Polistes Allergens

Thumbnail

D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives

Thumbnail

D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy

Thumbnail

D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts

Thumbnail

D3.424 - Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis

Thumbnail

D3.425 - Anaphylactic reaction to carpenter bee

Thumbnail

D3.426 - The Frequency of Previous Large Local Reactions in a Group of 158 Patients with a History of Systemic Reaction after Insect Sting

Thumbnail

D3.427 - Current practices in diagnosis and treatment of Hymenoptera venom allergy (HVA) in Poland

Thumbnail

D3.428 - CAP-Inhibition use to diagnose genuine double sensitization to vespoid venoms: description of a spanish cohort

Thumbnail

D2.163 - Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM